Karyopharm Therapeutics
KPTI
KPTI
114 hedge funds and large institutions have $58.6M invested in Karyopharm Therapeutics in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 24 increasing their positions, 33 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
27% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 33
48% less capital invested
Capital invested by funds: $113M → $58.6M (-$54.3M)
Holders
114
Holding in Top 10
–
Calls
$1.19M
Puts
$89K
Top Buyers
| 1 | +$1.24M | |
| 2 | +$1.2M | |
| 3 | +$1.04M | |
| 4 |
Millennium Management
New York
|
+$787K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$711K |
Top Sellers
| 1 | -$5.45M | |
| 2 | -$4.58M | |
| 3 | -$1.59M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.05M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$743K |